Suppr超能文献

在原位大鼠膀胱肿瘤模型中对光敏剂二磺化中位四苯基氯卟啉的研究。

Studies of the photosensitizer disulfonated meso-tetraphenyl chlorin in an orthotopic rat bladder tumor model.

作者信息

Baglo Yan, Peng Qian, Hagen Lars, Berg Kristian, Høgset Anders, Drabløs Finn, Gederaas Odrun A

机构信息

Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, N-7491 Trondheim, Norway.

Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, N-0310 Oslo, Norway.

出版信息

Photodiagnosis Photodyn Ther. 2015 Mar;12(1):58-66. doi: 10.1016/j.pdpdt.2014.12.005. Epub 2015 Jan 6.

Abstract

BACKGROUND

Photochemical internalization (PCI) is a novel technology for the release of a therapeutic molecule from endocytic vesicles into the cytosol of a cell. The release of molecules occurs after activation of an endocytic membrane-embedded photosensitizer by light. In this study uptake and localization of the photosensitizer disulfonated tetraphenyl chlorin (TPCS2a) were explored to optimize a PCI protocol in an orthotopic rat bladder tumor model.

METHODS

Female Fischer F344 rats were intravesically instilled with 0.4×10(6) AY-27 transitional carcinoma cells before allowing tumor growth for 14 days. The photosensitizer TPCS2a was intravesically instilled at different concentrations, and bladders were excised after different time intervals. The retention, penetration, and localization of intratumoral TPCS2a were explored ex vivo using fluorescence spectroscopy and fluorescence microscopy to determine an optimal PCI protocol. These results were compared to histological analysis of necrotic areas after activation of intratumoral TPCS2a by red light (652nm, 0.5J/cm(2)).

RESULTS

A superficial distribution pattern of the photosensitizer TPCS2a was seen in bladder tumor tissue, and TPCS2a was almost cleared from the tumors after 72h. The highest retention of TPCS2a was found at 24h after instillation when using a concentration of 3mg/ml.

CONCLUSION

An optimal PCI protocol was defined for the tumor model, including a 24-h TPCS2a-to-light interval and a dose of 3mg/ml TPCS2a. This protocol will be utilized for the study of PCI-enhanced therapeutic effects on non-muscle invasive bladder cancer, using a potent chemotherapeutic under an optimal light dose.

摘要

背景

光化学内化(PCI)是一种将治疗性分子从内吞小泡释放到细胞胞质溶胶中的新技术。分子的释放发生在内吞膜包埋的光敏剂被光激活之后。在本研究中,探索了光敏剂二磺酸四苯基氯卟啉(TPCS2a)的摄取和定位,以优化原位大鼠膀胱肿瘤模型中的PCI方案。

方法

雌性Fischer F344大鼠膀胱内灌注0.4×10⁶个AY - 27移行癌细胞,待肿瘤生长14天。以不同浓度膀胱内灌注光敏剂TPCS2a,在不同时间间隔后切除膀胱。使用荧光光谱和荧光显微镜在体外探索肿瘤内TPCS2a的保留、渗透和定位,以确定最佳PCI方案。将这些结果与用红光(652nm,0.5J/cm²)激活肿瘤内TPCS2a后坏死区域的组织学分析结果进行比较。

结果

在膀胱肿瘤组织中观察到光敏剂TPCS2a的浅表分布模式,并且在72小时后TPCS2a几乎从肿瘤中清除。当使用浓度为3mg/ml时,在灌注后24小时发现TPCS2a的保留率最高。

结论

为该肿瘤模型定义了最佳PCI方案,包括24小时的TPCS2a - 光照间隔和3mg/ml的TPCS2a剂量。该方案将用于研究在最佳光剂量下使用强效化疗药物时PCI增强对非肌肉浸润性膀胱癌的治疗效果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验